Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management. (2022)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2147/ptt.s328575
PubMed Identifier: 35024352
Publication URI: http://europepmc.org/abstract/MED/35024352
Type: Journal Article/Review
Volume: 12
Parent Publication: Psoriasis (Auckland, N.Z.)
ISSN: 2230-326X